ArticleMetabolomics : Official journal of the Metabolomic Society2025
Proteomic and metabolomic profiling of plasma reveals physiologic changes in patients with convalescent COVID-19.
Article in Metabolomics : Official journal of the Metabolomic Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundThis study aimed to analyze the molecular composition and physiological changes in the plasma of patients with convalescent coronavirus disease 2019 (COVID-19).
methodsPlasma samples from 29 hospitalized patients recovering from COVID-19 and 30 uninfected controls were analyzed using untargeted metabolomics and data-independent acquisition mass spectroscopy proteomic analyses. Integrative metabolomic-proteomic analysis was then conducted to construct a protein-metabolite interaction network.
resultsUntargeted metabolomic profiles revealed 415 differential metabolites, with 28.05% of the metabolites belonging to lipids and lipid-like molecules, most of which were upregulated in patients with convalescent COVID-19, such as sphingolipids. Differential metabolites were involved in taste transduction, thermogenesis, and sphingolipid metabolism. Proteomic analysis identified 947 differentially expressed proteins, which were mainly involved in immunoinflammation-related pathways, such as complement and coagulation cascades, neutrophil extracellular trap formation, and platelet activation. Several significant pathways were influenced by differential metabolites and proteins, such as estrogen signaling, ferroptosis, and neurodegeneration-associated pathways.
conclusionThis study revealed differential metabolite and protein compositions in the plasma of patients with convalescent COVID-19 compared with uninfected controls. The main physiological changes were associated with the pathology of this disease, suggesting that the phenotype of patients with convalescent COVID-19 did not return to a phenotype similar to that of uninfected controls.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.